To assess whether intratumoral Treg infiltration may also be affected by immunotherapy in breast cancer patients, we examined FOXP3 gene expression in sequential tumor biopsies obtained in the GELATO trial44. The gene discussed is FOXP3; the disease is breast carcinoma.